<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Jason Jarmacz Projects Portfolio - NeuroProgressive AI, IHEP, Mission Valley, JESS, DIPG AI Therapeutic Discovery">
    <title>Projects Portfolio | Jason Jarmacz - NeuroProgressive AI Evolution Strategist</title>
    <link rel="stylesheet" href="styles/main.css">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <link rel="stylesheet" href="styles/utilities.css">
    <link rel="stylesheet" href="styles/projects_portfolio.css">
</head>
<body>
    <!-- Navigation -->
    <nav class="main-nav" id="mainNav">
        <div class="nav-container">
            <div class="logo">
                <a href="index.html" aria-label="Jason Jarmacz home">
                    <img src="images/1000002043.jpg" alt="Jason Jarmacz logo" class="site-logo">
                    <span class="logo-text">JARMACZ</span>
                </a>
            </div>
            <ul class="nav-menu" id="navMenu">
                <li><a href="index.html#evolution-matrix">Evolution Matrix</a></li>
                <li><a href="index.html#frameworks">Frameworks</a></li>
                <li><a href="projects_portfolio.html">Projects</a></li>
                <li><a href="index.html#ventures">Ventures</a></li>
                <li><a href="#services">Services</a></li>
                <li><a href="index.html#contact">Engage</a></li>
            </ul>
            <div class="nav-toggle" id="navToggle">
                <span></span>
                <span></span>
                <span></span>
            </div>
        </div>
    </nav>

    <!-- Hero Section -->
    <section class="hero u-min-pad-120px-pad-80px">
        <div class="container">
            <h1 class="section-title u-fon-3rem-mar-20px">Strategic Projects Portfolio</h1>
            <p class="section-subtitle u-max-mar-0-auto">
                Comprehensive documentation of innovative frameworks driving transformative impact across healthcare, infrastructure, and AI alignment. Each project demonstrates mathematical rigor, regulatory compliance, and quantifiable outcomes.
            </p>
            <div class="hero-metrics u-max-mar-0-auto-2">
                <div class="metric">
                    <span class="metric-value">5</span>
                    <span class="metric-label">Active Strategic Projects</span>
                </div>
                <div class="metric">
                    <span class="metric-value">$1.3B</span>
                    <span class="metric-label">Combined Market Potential</span>
                </div>
                <div class="metric">
                    <span class="metric-value">87%</span>
                    <span class="metric-label">Average Risk Reduction</span>
                </div>
            </div>
        </div>
    </section>

    <!-- Projects Overview Section -->
    <section class="u-pad-80px-0 frameworks" id="projects-overview" >
        <div class="container">

            <!-- Project 1: NeuroProgressive AI Platform -->
            <div class="framework-item u-mar-80px">
                <div class="paper-header u-mar-20px-3">
                    <span class="paper-tag">BCI / Human-AI Symbiosis</span>
                    <span class="paper-date">$12.5B Market Opportunity</span>
                </div>
                <h3 class="u-fon-2-5rem-mar-20px">NeuroProgressive AI Platform</h3>
                <p class="u-col-accent-c-fon-1-2rem-mar-20px">
                    <strong>Vision:</strong> Revolutionary brain-computer interface platform enabling direct neural communication for individuals with severe motor impairments while pioneering Human-as-the-Loop AI alignment.
                </p>

                <!-- Mathematical Framework Preview -->
                <div class="equation-block u-mar-30px-0">
                    <h4 class="u-col-primary-mar-15px">Core Mathematical Framework: Human-as-the-Loop (HatL)</h4>
                    <p>Balances AI performance with human alignment through KL divergence minimization:</p>
                    $$J(\theta) = \mathbb{E}_{\tau \sim \pi_\theta}[R(\tau)] + \lambda \cdot D_{KL}(\pi_\theta || \pi_{human})$$
                    <p class="u-mar-15px"><strong>Implementation:</strong> Constitutional AI training loss function ensures AI decisions remain aligned with human values while optimizing task performance.</p>
                </div>

                <!-- Multi-Stakeholder Translations -->
                <div class="u-dis-grid-gri-gap-mar-30px-0-2">
                    <div class="u-bac-rgba-0-2-bor-pad-20px-bor">
                        <h4 class="u-col-primary-mar-10px"><i class="fas fa-chart-line"></i> C-Suite Translation</h4>
                        <p class="u-col-neutral-fon-0-95re">
                            <strong>Market Position:</strong> First-mover advantage in $12.5B assistive BCI market with 87% AI alignment risk reduction. Targets 400K ALS/locked-in syndrome patients globally.
                        </p>
                        <p class="u-col-neutral-fon-0-9rem-mar-10px">
                            <strong>ROI:</strong> 40% capital savings vs. traditional development through human-guided model evolution.
                        </p>
                    </div>
                    <div class="u-bac-rgba-123-bor-pad-20px-bor">
                        <h4 class="u-col-primary-mar-10px-2"><i class="fas fa-code"></i> Engineering Translation</h4>
                        <p class="u-col-neutral-fon-0-95re">
                            <strong>Tech Stack:</strong> EEG/ECoG signal processing + Deep Learning (RNNs/Transformers) + RLHF pipeline for adaptive decoding.
                        </p>
                        <p class="u-col-neutral-fon-0-9rem-mar-10px">
                            <strong>Performance:</strong> 80 words/min synthesized speech, 99.7% uptime, real-time neural decoding at 200Hz.
                        </p>
                    </div>
                    <div class="u-bac-rgba-255-bor-pad-20px-bor">
                        <h4 class="u-col-accent-m-mar-10px"><i class="fas fa-cogs"></i> Operations Translation</h4>
                        <p class="u-col-neutral-fon-0-95re">
                            <strong>Clinical Workflow:</strong> FDA Class III device pathway with HIPAA-compliant data handling and IRB-approved human subjects protocols.
                        </p>
                        <p class="u-col-neutral-fon-0-9rem-mar-10px">
                            <strong>Monitoring:</strong> Continuous signal quality validation with automated anomaly detection.
                        </p>
                    </div>
                </div>

                <!-- Key Metrics -->
                <div class="u-bac-rgba-0-0-pad-25px-bor-mar-30px-0">
                    <h4 class="u-col-neutral-mar-20px"><i class="fas fa-chart-bar"></i> Quantifiable Impact Metrics</h4>
                    <div class="u-dis-grid-gri-gap">
                        <div>
                            <div class="u-col-accent-c-fon-2rem-fon-bold">80</div>
                            <div class="paper-date">Words/min synthesized speech</div>
                        </div>
                        <div>
                            <div class="u-col-accent-c-fon-2rem-fon-bold">87%</div>
                            <div class="paper-date">AI alignment risk reduction</div>
                        </div>
                        <div>
                            <div class="u-col-accent-c-fon-2rem-fon-bold">40%</div>
                            <div class="paper-date">Capital savings vs traditional dev</div>
                        </div>
                        <div>
                            <div class="u-col-accent-c-fon-2rem-fon-bold">99.7%</div>
                            <div class="paper-date">System uptime guarantee</div>
                        </div>
                    </div>
                </div>

                <!-- Regulatory Framework -->
                <div class="u-bac-rgba-123-bor-1px-soli-pad-25px-bor-mar-30p">
                    <h4 class="u-col-neutral-mar-15px"><i class="fas fa-shield-alt"></i> Regulatory & Compliance Framework</h4>
                    <ul class="card-features u-col-neutral-">
                        <li>FDA Class III Medical Device Pathway (PMA submission)</li>
                        <li>HIPAA Privacy & Security Rules compliance</li>
                        <li>IRB-approved human subjects research protocols</li>
                        <li>ISO 13485 quality management systems</li>
                        <li>Constitutional AI ethical alignment framework</li>
                    </ul>
                </div>

                <div class="u-tex-center-mar-40px cta-group">
                    <a class="u-fon-1-1rem-pad-15px-4 btn btn-primary" href="neuroprogressive-ai.html">
                        <i class="fas fa-brain"></i> View Full Technical Deep Dive
                    </a>
                    <a class="u-fon-1-1rem-pad-15px-4 btn btn-secondary" href="docs/NeuroProgressive_AI.pdf" download>
                        Download Proposal (PDF)
                    </a>
                </div>
            </div>

            <!-- Project 2: IHEP (Integrated Health Empowerment Program) -->
            <div class="framework-item u-mar-80px">
                <div class="paper-header u-mar-20px-3">
                    <span class="paper-tag">Healthcare AI / NIST Compliance</span>
                    <span class="paper-date">350-5,000 Patient Capacity</span>
                </div>
                <h3 class="u-fon-2-5rem-mar-20px">IHEP: Integrated Health Empowerment Program</h3>
                <p class="u-col-accent-c-fon-1-2rem-mar-20px">
                    <strong>Vision:</strong> AI-powered comprehensive healthcare platform for HIV/AIDS care with Zero Trust security architecture, targeting near-term care optimization and long-term therapeutic breakthroughs.
                </p>

                <!-- Mathematical Framework Preview -->
                <div class="equation-block u-mar-30px-0">
                    <h4 class="u-col-primary-mar-15px">Core Framework: Patient Digital Twin with Recursive Learning</h4>
                    <p>Bayesian update framework for continuous patient state estimation:</p>
                    $$P(\theta_{t+1}|\mathcal{D}) \propto P(\mathcal{D}_{t+1}|\theta_{t+1}) \cdot P(\theta_{t+1}|\mathcal{D}_{1:t})$$
                    <p class="u-mar-15px"><strong>Implementation:</strong> Real-time integration of clinical observations, lab results, and behavioral data to maintain probabilistic patient health model with predictive alerts.</p>
                </div>

                <!-- NIST Compliance Architecture -->
                <div class="u-bac-rgba-0-0-pad-25px-bor-mar-30px-0-bor">
                    <h4 class="u-col-primary-mar-20px"><i class="fas fa-lock"></i> NIST AI RMF 1.0 Compliance Architecture</h4>
                    <div class="u-dis-grid-gri-gap-3">
                        <div>
                            <strong class="framework-content strong">GOVERN:</strong>
                            <span class="u-col-neutral-fon-0-9rem"> AI governance policies, risk assessment protocols</span>
                        </div>
                        <div>
                            <strong class="framework-content strong">MAP:</strong>
                            <span class="u-col-neutral-fon-0-9rem"> Context identification, impact analysis, risk categorization</span>
                        </div>
                        <div>
                            <strong class="framework-content strong">MEASURE:</strong>
                            <span class="u-col-neutral-fon-0-9rem"> Performance metrics, bias detection, safety monitoring</span>
                        </div>
                        <div>
                            <strong class="framework-content strong">MANAGE:</strong>
                            <span class="u-col-neutral-fon-0-9rem"> Incident response, continuous improvement, documentation</span>
                        </div>
                    </div>
                    <p class="u-col-neutral-mar-20px-fon-0-95re">
                        <strong>Additional Standards:</strong> NIST SP 800-53r5 (Security Controls), SP 800-207 (Zero Trust Architecture), FBI CJIS Security Policy v5.9.1, NISTIR 8259A (IoT Device Security)
                    </p>
                </div>

                <!-- Multi-Stakeholder Translations -->
                <div class="u-dis-grid-gri-gap-mar-30px-0-2">
                    <div class="u-bac-rgba-0-2-bor-pad-20px-bor">
                        <h4 class="u-col-primary-mar-10px"><i class="fas fa-chart-line"></i> C-Suite Translation</h4>
                        <p class="u-col-neutral-fon-0-95re">
                            <strong>Value Proposition:</strong> 35% care cost reduction per patient annually while improving viral suppression rates to ≥95% (vs 87% national average).
                        </p>
                        <p class="u-col-neutral-fon-0-9rem-mar-10px">
                            <strong>Funding Path:</strong> SBIR Phase I ($275K) → Phase II ($2M) → Phase III ($10M+) with clear regulatory compliance reducing approval risk.
                        </p>
                    </div>
                    <div class="u-bac-rgba-123-bor-pad-20px-bor">
                        <h4 class="u-col-primary-mar-10px-2"><i class="fas fa-code"></i> Engineering Translation</h4>
                        <p class="u-col-neutral-fon-0-95re">
                            <strong>Architecture:</strong> Microservices with Zero Trust network segmentation, end-to-end encryption, and containerized deployment for scalability.
                        </p>
                        <p class="u-col-neutral-fon-0-9rem-mar-10px">
                            <strong>AI Models:</strong> Transformer-based predictive models for viral load forecasting + Generative Bio-AI for therapeutic discovery.
                        </p>
                    </div>
                    <div class="u-bac-rgba-255-bor-pad-20px-bor">
                        <h4 class="u-col-accent-m-mar-10px"><i class="fas fa-cogs"></i> Operations Translation</h4>
                        <p class="u-col-neutral-fon-0-95re">
                            <strong>Workflow Integration:</strong> EHR interoperability (FHIR/HL7), automated appointment reminders, medication adherence tracking.
                        </p>
                        <p class="u-col-neutral-fon-0-9rem-mar-10px">
                            <strong>Monitoring:</strong> Real-time dashboards for care coordinators with predictive alerts for intervention opportunities.
                        </p>
                    </div>
                </div>

                <!-- Key Metrics -->
                <div class="u-bac-rgba-0-0-pad-25px-bor-mar-30px-0">
                    <h4 class="u-col-neutral-mar-20px"><i class="fas fa-chart-bar"></i> Quantifiable Impact Metrics</h4>
                    <div class="u-dis-grid-gri-gap">
                        <div>
                            <div class="u-col-accent-c-fon-2rem-fon-bold">350-5K</div>
                            <div class="paper-date">Patient capacity (scalable)</div>
                        </div>
                        <div>
                            <div class="u-col-accent-c-fon-2rem-fon-bold">≥95%</div>
                            <div class="paper-date">Viral suppression target</div>
                        </div>
                        <div>
                            <div class="u-col-accent-c-fon-2rem-fon-bold">35%</div>
                            <div class="paper-date">Care cost reduction annually</div>
                        </div>
                        <div>
                            <div class="u-col-accent-c-fon-2rem-fon-bold">100%</div>
                            <div class="paper-date">NIST AI RMF + Zero Trust</div>
                        </div>
                    </div>
                </div>

                <!-- 10-Year Roadmap to Cure -->
                <div class="u-bac-rgba-123-bor-1px-soli-pad-25px-bor-mar-30p">
                    <h4 class="u-col-neutral-mar-15px"><i class="fas fa-map-signs"></i> 10-Year Roadmap to HIV/AIDS Cure</h4>
                    <ul class="card-features u-col-neutral-">
                        <li><strong>Years 0-2:</strong> SBIR Phase I/II funding, MVP deployment with 350 patients, establish baseline metrics</li>
                        <li><strong>Years 3-5:</strong> Scale to 5,000+ patients, initiate Generative Bio-AI therapeutic discovery pipeline</li>
                        <li><strong>Years 6-8:</strong> Clinical trials for AI-discovered latency-reversing agents targeting viral reservoirs</li>
                        <li><strong>Years 9-10:</strong> Combination therapy trials for functional cure (undetectable viral load without ART)</li>
                    </ul>
                </div>

                <div class="u-tex-center-mar-40px cta-group">
                    <a class="u-fon-1-1rem-pad-15px-4 btn btn-primary" href="ihep.html">
                        <i class="fas fa-heartbeat"></i> View Full IHEP Framework
                    </a>
                    <a class="u-fon-1-1rem-pad-15px-4 btn btn-secondary" href="docs/IHEP_Executive_Summary.pdf" download>
                        Download IHEP Executive Summary
                    </a>
                </div>
            </div>

            <!-- Project 3: Mission Valley Property Acquisition -->
            <div class="framework-item u-mar-80px">
                <div class="paper-header u-mar-20px-3">
                    <span class="paper-tag">Real Estate / Strategic Investment</span>
                    <span class="paper-date">$215M Asset Value</span>
                </div>
                <h3 class="u-fon-2-5rem-mar-20px">Mission Valley Strategic Property Acquisition</h3>
                <p class="u-col-accent-c-fon-1-2rem-mar-20px">
                    <strong>Vision:</strong> Multi-scenario acquisition strategy for 4.2-acre Mission Valley property (San Diego, CA) targeting UCSD Health, faith-based organizations, or biotech corporations with 30-year investment thesis.
                </p>

                <!-- Investment Thesis -->
                <div class="u-bac-rgba-0-0-pad-25px-bor-mar-30px-0-bor-2">
                    <h4 class="u-col-accent-c-mar-20px"><i class="fas fa-chart-line"></i> 30-Year Investment Analysis</h4>
                    <div class="u-dis-grid-gri-gap-9">
                        <div>
                            <strong class="u-col-primary-fon-2rem">$215M</strong>
                            <div class="contact-item a">Current assessed asset value</div>
                        </div>
                        <div>
                            <strong class="u-col-primary-fon-2rem">4.89×</strong>
                            <div class="contact-item a">Equity multiple (30-year)</div>
                        </div>
                        <div>
                            <strong class="u-col-primary-fon-2rem">18-25%</strong>
                            <div class="contact-item a">Sponsor IRR range</div>
                        </div>
                        <div>
                            <strong class="u-col-primary-fon-2rem">$1.1B</strong>
                            <div class="contact-item a">Regional economic impact</div>
                        </div>
                    </div>
                </div>

                <!-- Three Acquisition Scenarios -->
                <div class="u-mar-30px-0">
                    <h4 class="u-col-neutral-mar-20px"><i class="fas fa-sitemap"></i> Three Strategic Acquisition Models</h4>

                    <div class="u-dis-grid-gri-gap-5">
                        <!-- UCSD Health Model -->
                        <div class="u-bac-rgba-0-2-bor-1px-soli-pad-20px-bor">
                            <h5 class="u-col-primary-mar-10px">Model 1: UCSD Health Expansion</h5>
                            <p class="u-col-neutral-fon-0-95re-mar-15px">
                                Satellite clinic for specialty care (oncology, neurology, cardiology) leveraging UCSD's academic medical center reputation.
                            </p>
                            <ul class="card-features u-fon-0-9rem-col-neutral-">
                                <li>Annual patient volume: 25,000-35,000</li>
                                <li>Supports UCSD's regional healthcare access mission</li>
                                <li>Integration with existing EMR infrastructure</li>
                                <li>Research partnership opportunities</li>
                            </ul>
                        </div>

                        <!-- Faith-Based Model -->
                        <div class="u-bac-rgba-123-bor-1px-soli-pad-20px-bor">
                            <h5 class="u-col-primary-mar-10px-2">Model 2: Faith-Based Community Hub</h5>
                            <p class="u-col-neutral-fon-0-95re-mar-15px">
                                Multi-denominational worship center with integrated social services (food bank, job training, mental health counseling).
                            </p>
                            <ul class="card-features u-fon-0-9rem-col-neutral-">
                                <li>Weekly attendance capacity: 2,500+</li>
                                <li>501(c)(3) tax advantages</li>
                                <li>Community impact: 10,000+ served annually</li>
                                <li>Partnerships with local nonprofits</li>
                            </ul>
                        </div>

                        <!-- Corporate Model -->
                        <div class="u-bac-rgba-255-bor-1px-soli-pad-20px-bor">
                            <h5 class="u-col-accent-m-mar-10px">Model 3: Biotech Corporate Campus</h5>
                            <p class="u-col-neutral-fon-0-95re-mar-15px">
                                R&D facility for life sciences corporations (Illumina, Novartis profiles) with wet lab infrastructure and office space.
                            </p>
                            <ul class="card-features u-fon-0-9rem-col-neutral-">
                                <li>Lab space: 80,000-100,000 sq ft</li>
                                <li>Jobs created: 400-600 high-wage positions</li>
                                <li>Innovation ecosystem integration</li>
                                <li>Tax incentive eligibility (CA Competes)</li>
                            </ul>
                        </div>
                    </div>
                </div>

                <!-- Buyer Profiles -->
                <div class="u-bac-rgba-0-0-pad-25px-bor-mar-30px-0">
                    <h4 class="u-col-neutral-mar-15px"><i class="fas fa-handshake"></i> Strategic Buyer Profiles & LOI Frameworks</h4>
                    <p class="u-col-neutral-mar-20px-2">
                        Detailed Letters of Intent (LOI) templates prepared for:
                    </p>
                    <div class="u-dis-grid-gri-gap-3">
                        <div>
                            <strong class="framework-content strong">Illumina Inc.</strong>
                            <span class="u-col-neutral-fon-0-9rem-dis-block">Genomics sequencing R&D expansion to support next-gen platforms</span>
                        </div>
                        <div>
                            <strong class="framework-content strong">Novartis</strong>
                            <span class="u-col-neutral-fon-0-9rem-dis-block">Cell & gene therapy manufacturing proximity to Torrey Pines campus</span>
                        </div>
                        <div>
                            <strong class="framework-content strong">UCSD Health</strong>
                            <span class="u-col-neutral-fon-0-9rem-dis-block">Mission Valley clinic addressing East County healthcare gap</span>
                        </div>
                    </div>
                </div>

                <div class="u-tex-center-mar-40px cta-group">
                    <a class="u-fon-1-1rem-pad-15px-4 btn btn-primary" href="mission-valley.html">
                        <i class="fas fa-building"></i> View Full Project Details
                    </a>
                    <a class="u-fon-1-1rem-pad-15px-4 btn btn-secondary" href="docs/Mission_Valley_Property_Acquisition_Strategic_Potentials_and_Analysis.pdf" download>
                        Download Mission Valley Playbook
                    </a>
                </div>
            </div>

            <!-- Project 4: JESS Security Pipeline -->
            <div class="framework-item u-mar-80px">
                <div class="paper-header u-mar-20px-3">
                    <span class="paper-tag">Critical Infrastructure / Zero Trust</span>
                    <span class="paper-date">DHS S&T Eligible</span>
                </div>
                <h3 class="u-fon-2-5rem-mar-20px">JESS: Joint Energy Security System</h3>
                <p class="u-col-accent-c-fon-1-2rem-mar-20px">
                    <strong>Vision:</strong> Secure building automation pipeline integrating wearable body area networks (WBAN) with BACnet/SC infrastructure, delivering dual-use value for first responders and commercial facilities.
                </p>

                <!-- Technical Architecture -->
                <div class="u-bac-rgba-0-0-pad-25px-bor-mar-30px-0-bor">
                    <h4 class="u-col-primary-mar-20px"><i class="fas fa-network-wired"></i> Technical Architecture: WBAN → BACnet/SC Pipeline</h4>
                    <div class="u-col-neutral-fon-0-95re-lin">
                        <p><strong>Data Flow:</strong> Physiological sensors (heart rate, body temp, location) → Edge device aggregation → TLS/PKI encrypted transmission → BACnet/SC building controller → Zero Trust network segmentation → Analytics dashboard</p>
                        <p class="u-mar-15px"><strong>Use Cases:</strong></p>
                        <ul class="card-features">
                            <li><strong>First Responders:</strong> Real-time health monitoring in hazardous environments (fires, chemical spills)</li>
                            <li><strong>Commercial Buildings:</strong> Occupancy-based HVAC optimization for energy efficiency</li>
                            <li><strong>Healthcare Facilities:</strong> Patient vitals integration with building climate control</li>
                        </ul>
                    </div>
                </div>

                <!-- NIST & CJIS Compliance -->
                <div class="u-bac-rgba-123-bor-1px-soli-pad-25px-bor-mar-30p">
                    <h4 class="u-col-neutral-mar-15px"><i class="fas fa-shield-alt"></i> Compliance Framework</h4>
                    <ul class="card-features u-col-neutral-">
                        <li><strong>NIST SP 800-207:</strong> Zero Trust Architecture with continuous authentication</li>
                        <li><strong>NIST SP 800-53r5:</strong> Security controls for federal systems (AC, AU, SC families)</li>
                        <li><strong>FBI CJIS Security Policy v6.0:</strong> Law enforcement data handling requirements</li>
                        <li><strong>BACnet/SC:</strong> Secure Connect protocol (TLS 1.2+, X.509 certificates, PKI infrastructure)</li>
                    </ul>
                </div>

                <!-- Dual-Use Value Proposition -->
                <div class="u-dis-grid-gri-gap-mar-30px-0-2">
                    <div class="u-bac-rgba-0-2-bor-pad-20px-bor">
                        <h4 class="u-col-primary-mar-10px"><i class="fas fa-fire-extinguisher"></i> First Responder Value</h4>
                        <p class="u-col-neutral-fon-0-95re">
                            Incident command visibility into firefighter health status during operations, enabling proactive safety interventions.
                        </p>
                        <p class="u-col-neutral-fon-0-9rem-mar-10px">
                            <strong>Funding:</strong> DHS S&T First Responder Technology Program eligibility
                        </p>
                    </div>
                    <div class="u-bac-rgba-123-bor-pad-20px-bor">
                        <h4 class="u-col-primary-mar-10px-2"><i class="fas fa-building"></i> Commercial Value</h4>
                        <p class="u-col-neutral-fon-0-95re">
                            15-30% energy cost reduction through occupancy-aware building automation + ESG reporting advantages.
                        </p>
                        <p class="u-col-neutral-fon-0-9rem-mar-10px">
                            <strong>Market:</strong> $100B+ smart buildings sector with sustainability mandates
                        </p>
                    </div>
                </div>

                <div class="u-tex-center-mar-40px cta-group">
                    <a class="u-fon-1-1rem-pad-15px-4 btn btn-primary" href="jess.html">
                        <i class="fas fa-shield-alt"></i> View Full Project Details
                    </a>
                    <a class="u-fon-1-1rem-pad-15px-4 btn btn-secondary" href="docs/JESS__Executive_Summary.pdf" download>
                        Download JESS Executive Summary
                    </a>
                </div>
            </div>

            <!-- Project 5: DIPG AI Therapeutic Discovery -->
            <div class="framework-item u-mar-80px">
                <div class="paper-header u-mar-20px-3">
                    <span class="paper-tag">Generative Bio-AI / Rare Disease</span>
                    <span class="paper-date">Pediatric Oncology</span>
                </div>
                <h3 class="u-fon-2-5rem-mar-20px">DIPG AI Therapeutic Discovery Platform</h3>
                <p class="u-col-accent-c-fon-1-2rem-mar-20px">
                    <strong>Vision:</strong> Generative AI-driven drug discovery pipeline targeting Diffuse Intrinsic Pontine Glioma (DIPG), a universally fatal pediatric brain cancer with <1% survival rate and 200+ failed clinical trials.
                </p>

                <!-- Unmet Clinical Need -->
                <div class="u-bac-rgba-255-bor-2px-soli-pad-25px-bor-mar-30p">
                    <h4 class="u-col-accent-m-mar-15px"><i class="fas fa-exclamation-triangle"></i> Critical Unmet Medical Need</h4>
                    <div class="u-dis-grid-gri-gap-col-neutral-">
                        <div>
                            <div class="u-fon-2rem-fon-bold-col-neutral-">&lt;1%</div>
                            <div class="u-fon-0-9rem-col-neutral-">5-year survival rate</div>
                        </div>
                        <div>
                            <div class="u-fon-2rem-fon-bold-col-neutral-">200+</div>
                            <div class="u-fon-0-9rem-col-neutral-">Failed clinical trials</div>
                        </div>
                        <div>
                            <div class="u-fon-2rem-fon-bold-col-neutral-">300</div>
                            <div class="u-fon-0-9rem-col-neutral-">US cases annually</div>
                        </div>
                        <div>
                            <div class="u-fon-2rem-fon-bold-col-neutral-">9 mos</div>
                            <div class="u-fon-0-9rem-col-neutral-">Median survival</div>
                        </div>
                    </div>
                </div>

                <!-- AI-Driven Solution -->
                <div class="u-bac-rgba-0-0-pad-25px-bor-mar-30px-0-bor-2">
                    <h4 class="u-col-accent-c-mar-20px"><i class="fas fa-robot"></i> Generative AI Therapeutic Discovery Pipeline</h4>
                    <p class="u-col-neutral-mar-20px-2">
                        <strong>Approach:</strong> Train generative models (VAEs, GANs, Transformers) on molecular databases to design novel small molecules targeting DIPG-specific vulnerabilities:
                    </p>
                    <ul class="card-features u-col-neutral-">
                        <li><strong>Target 1:</strong> DHODH inhibition (dihydroorotate dehydrogenase) to block pyrimidine synthesis in H3K27M-mutant tumor cells</li>
                        <li><strong>Target 2:</strong> Blood-brain barrier penetration optimization using in silico BBB prediction models</li>
                        <li><strong>Target 3:</strong> Reduced systemic toxicity through selective tumor microenvironment activation</li>
                        <li><strong>Workflow:</strong> AI candidate generation → Virtual screening (ADMET) → In vitro validation → Patient-derived xenograft (PDX) testing → IND filing</li>
                    </ul>
                </div>

                <!-- Timeline Comparison -->
                <div class="u-mar-30px-0">
                    <h4 class="u-col-neutral-mar-20px"><i class="fas fa-clock"></i> Development Timeline: AI vs Traditional</h4>
                    <div class="u-dis-grid-gri-gap-10">
                        <div class="u-bac-rgba-0-2-bor-2px-soli-pad-20px-bor">
                            <h5 class="u-col-primary-mar-15px">AI-Driven Approach</h5>
                            <ul class="card-features u-col-neutral-fon-0-95re">
                                <li><strong>Months 0-6:</strong> Model training, candidate generation (10,000+ molecules)</li>
                                <li><strong>Months 7-9:</strong> Virtual screening, top 100 candidates</li>
                                <li><strong>Months 10-12:</strong> In vitro validation, lead optimization</li>
                                <li><strong>Total:</strong> <strong class="framework-content strong">12 months</strong> to IND-ready candidate</li>
                            </ul>
                        </div>
                        <div class="u-bac-rgba-123-bor-2px-soli-pad-20px-bor">
                            <h5 class="u-col-primary-mar-15px-2">Traditional Approach</h5>
                            <ul class="card-features u-col-neutral-fon-0-95re">
                                <li><strong>Years 1-2:</strong> High-throughput screening of compound libraries</li>
                                <li><strong>Years 3-4:</strong> Lead optimization through iterative SAR studies</li>
                                <li><strong>Year 5:</strong> Preclinical toxicology and IND preparation</li>
                                <li><strong>Total:</strong> <strong class="u-col-accent-m">5+ years</strong> to IND-ready candidate</li>
                            </ul>
                        </div>
                    </div>
                </div>

                <!-- Funding & Partnership Opportunities -->
                <div class="u-bac-rgba-123-bor-1px-soli-pad-25px-bor-mar-30p">
                    <h4 class="u-col-neutral-mar-15px"><i class="fas fa-hands-helping"></i> Funding & Partnership Opportunities</h4>
                    <ul class="card-features u-col-neutral-">
                        <li><strong>NIH Funding:</strong> NCI SBIR/STTR for rare pediatric cancers (Phase I: $400K, Phase II: $2.5M)</li>
                        <li><strong>Foundation Support:</strong> DIPG Collaborative, ChadTough Foundation, Michael Mosier Defeat DIPG Foundation</li>
                        <li><strong>Pharma Partnerships:</strong> In-licensing opportunities for biotech/pharma with oncology pipelines</li>
                        <li><strong>Academic Collaborations:</strong> Stanford DIPG Center, Dana-Farber, Memorial Sloan Kettering</li>
                    </ul>
                </div>

                <div class="u-tex-center-mar-40px cta-group">
                    <a class="u-fon-1-1rem-pad-15px-4 btn btn-primary" href="dipg.html">
                        <i class="fas fa-dna"></i> View Full Project Details
                    </a>
                    <a class="u-fon-1-1rem-pad-15px-4 btn btn-secondary" href="docs/SBIRNovelInnovationProposal.pdf" download>
                        Download DIPG SBIR Proposal
                    </a>
                </div>
            </div>

        </div>
    </section>

    <!-- Service Offerings Section -->
    <section class="u-pad-80px-0-bac-linear-g research-cta" id="services" >
        <div class="container">
            <h2 class="section-title u-fon-2-5rem-mar-20px">Transform Your Vision Into Reality</h2>
            <p class="section-subtitle u-max-mar-0-auto-3">
                Leverage my expertise in AI strategy, technical documentation, and innovation frameworks to accelerate your most ambitious projects.
            </p>

            <div class="u-dis-grid-gri-gap-mar-60px">
                <!-- Service 1: Executive Documentation Suite -->
                <div class="u-bac-rgba-0-2-bor-2px-soli-bor-pad-30px">
                    <div class="u-fon-2-5rem-col-primary-mar-15px">
                        <i class="fas fa-file-alt"></i>
                    </div>
                    <h3 class="u-col-neutral-mar-10px-2">Executive Documentation Suite</h3>
                    <div class="u-col-accent-c-fon-1-5rem-fon-bold-mar-15px">$5K - $25K</div>
                    <p class="u-col-neutral-mar-20px-2">
                        SBIR/STTR proposals, business plans, white papers, and technical specifications that translate complex innovations into fundable narratives.
                    </p>
                    <ul class="card-features u-fon-0-95re-col-neutral-">
                        <li>Grant proposal writing (NIH, NSF, DOE, DHS)</li>
                        <li>Investor pitch decks & business plans</li>
                        <li>Technical white papers & case studies</li>
                        <li>Regulatory compliance documentation</li>
                    </ul>
                </div>

                <!-- Service 2: LLM Training & Sanitization -->
                <div class="u-bac-rgba-123-bor-2px-soli-bor-pad-30px">
                    <div class="u-fon-2-5rem-col-primary-mar-15px-2">
                        <i class="fas fa-brain"></i>
                    </div>
                    <h3 class="u-col-neutral-mar-10px-2">LLM Training & Sanitization</h3>
                    <div class="u-col-accent-c-fon-1-5rem-fon-bold-mar-15px">$50K - $250K</div>
                    <p class="u-col-neutral-mar-20px-2">
                        Constitutional AI, RLHF pipelines, and adversarial sanitization protocols to ensure your AI systems are aligned, secure, and compliant.
                    </p>
                    <ul class="card-features u-fon-0-95re-col-neutral-">
                        <li>Constitutional AI training frameworks</li>
                        <li>RLHF (Reinforcement Learning from Human Feedback)</li>
                        <li>Prompt injection & jailbreak defense</li>
                        <li>NIST AI RMF compliance implementation</li>
                    </ul>
                </div>

                <!-- Service 3: Evolution Strategy Consulting -->
                <div class="u-bac-rgba-255-bor-2px-soli-bor-pad-30px">
                    <div class="u-fon-2-5rem-col-accent-m-mar-15px">
                        <i class="fas fa-chess-knight"></i>
                    </div>
                    <h3 class="u-col-neutral-mar-10px-2">Evolution Strategy Consulting</h3>
                    <div class="u-col-accent-c-fon-1-5rem-fon-bold-mar-15px">$15K/month</div>
                    <p class="u-col-neutral-mar-20px-2">
                        Ongoing strategic advisory for technology due diligence, innovation roadmapping, and AI integration across your organization.
                    </p>
                    <ul class="card-features u-fon-0-95re-col-neutral-">
                        <li>Technology landscape analysis</li>
                        <li>AI implementation roadmaps</li>
                        <li>Risk assessment & mitigation strategies</li>
                        <li>Executive AI literacy training</li>
                    </ul>
                </div>
            </div>

            <div class="metric">
                <a class="u-fon-1-2rem-pad-18px-5 btn btn-primary" href="index.html#contact" >
                    <i class="fas fa-rocket"></i> Let's Collaborate
                </a>
            </div>
        </div>
    </section>

    <!-- Footer -->
    <footer class="site-footer">
        <div class="container">
            <div class="footer-content">
                <div class="footer-section">
                    <h4>Jason Jarmacz</h4>
                    <p>NeuroProgressive AI Evolution Strategist</p>
                    <p class="footer-tagline">"Advancing with strict moral compass, letting discoveries define ambitions."</p>
                </div>
                <div class="footer-section">
                    <h4>Projects</h4>
                    <ul>
                        <li><a href="neuroprogressive-ai.html">NeuroProgressive AI Platform</a></li>
                        <li><a href="ihep.html">IHEP Framework</a></li>
                        <li><a href="#projects-overview">Mission Valley Property</a></li>
                        <li><a href="#projects-overview">JESS Security Pipeline</a></li>
                        <li><a href="#projects-overview">DIPG AI Therapeutic</a></li>
                    </ul>
                </div>
                <div class="footer-section">
                    <h4>Services</h4>
                    <ul>
                        <li><a href="#services">Executive Documentation</a></li>
                        <li><a href="#services">LLM Training & Sanitization</a></li>
                        <li><a href="#services">Evolution Strategy Consulting</a></li>
                    </ul>
                </div>
                <div class="footer-section">
                    <h4>Connect</h4>
                    <ul>
                        <li><a href="mailto:jayjarmacz@gmail.com">jayjarmacz@gmail.com</a></li>
                        <li><a href="tel:+19175668112">(917) 566-8112</a></li>
                        <li><a href="https://linkedin.com/in/omniunum" target="_blank">LinkedIn</a></li>
                        <li><a href="index.html">Home</a></li>
                    </ul>
                </div>
            </div>
            <div class="footer-bottom">
                <p>&copy; 2025 Jason Jarmacz. All rights reserved.</p>
                <p>Hosted at jarmacz.com (162.215.85.33) | SSL/TLS Secured</p>
            </div>
        </div>
    </footer>

    <!-- Scripts -->
    <script>
    // MathJax Configuration
    window.MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']]
        },
        svg: {
            fontCache: 'global'
        },
        chtml: {
            mtextInheritFont: true
        },
        startup: {
            ready: () => {
                MathJax.startup.defaultReady();
                MathJax.startup.promise.then(() => {
                    const style = document.createElement('style');
                    style.textContent = `
                        mjx-container, mjx-container * {
                            color: #00f5ff !important;
                        }
                        mjx-math {
                            color: #00f5ff !important;
                        }
                    `;
                    document.head.appendChild(style);
                });
            }
        }
    };
    </script>
    <script src="https://code.jquery.com/jquery-3.6.0.slim.min.js" integrity="sha256-u7e5khyithlIdTpu22PHhENmPcRdFiHRjhAuHcs05RI=" crossorigin="anonymous"></script>
    <script src="js/main.js"></script>
</body>
</html>
